1.
|
Phase: Phase III Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI, Pharmaceutical / Industry Protocol IDs: CCCGHS-NCI-T98-0085, NCI-T98-0085, NCI-99-C-0051B, T98-0085, NCT00019682
|
|
2.
|
Phase: Phase III Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000067568, U10CA021115, ECOG-4697, SWOG-E4697, E4697, NCT00005034
|
|
3.
|
Phase: Phase II, Phase I Type: Treatment Status: Completed Age: Over 18 Sponsor: NCI, Other Protocol IDs: DM97-325, R01CA081247, P30CA016672, MDA-DM-97325, NCI-T98-0017, CDR0000067600, T98-0017, NCT00004918
|
|
4.
|
Phase: Phase II, Phase I Type: Treatment Status: Completed Age: Over 18 Sponsor: NCI, Other Protocol IDs: CDR0000067782, P30CA016042, UCLA-9905003, NCI-H00-0053, NCT00005629
|
|
5.
|
Phase: Phase II, Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: UVACC-MEL-41, UVACC-28502, UVACC-HIC-10464, NCT00089219
|
|
6.
|
Phase: Phase II, Phase I Type: Treatment Status: Closed Age: Over 18 Sponsor: NCI Protocol IDs: NCI-04-CC-0118, NCT00112541
|
|
7.
|
Phase: Phase II, Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: UVACC-HIC-11491, Mel 44, UVACC-34104, UVACC-MEL-44, UVACC-GCRC-CLS013, UVACC-HITC-02620, MDA-2005-0070, NCT00118274
|
|
8.
|
Phase: Phase II, Phase I Type: Treatment Status: Temporarily closed Age: 18 and over Sponsor: Other Protocol IDs: LUD2003-007, NCT00145158
|
|
9.
|
Phase: Phase II, Phase I Type: Treatment Status: Closed Age: 20 to 80 Sponsor: Other Protocol IDs: FPCR1R2-2, NCT00655785
|
|
10.
|
Phase: Phase II, Phase I Type: Treatment Status: Closed Age: 20 to 85 Sponsor: Other Protocol IDs: IMU-H21-40-P?/?, NCT01225471
|
|
11.
|
Phase: Phase II, Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: UPCC 29810, NCT01312389
|
|
12.
|
Phase: Phase II, Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI, NIH WGMCC Protocol IDs: 030162, 03-C-0162, NCI-5855, CDR0000304438, NCT00062036
|
|
13.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-97-C-0118, NCI-T97-0009, T97-0009
|
|
14.
|
Phase: Phase II Type: Treatment Status: Completed Age: 16 and over Sponsor: NCI Protocol IDs: NCI-98-C-0022, NCI-T97-0088, T97-0088, NCT00019383
|
|
15.
|
Phase: Phase II Type: Treatment Status: Completed Age: 16 and over Sponsor: NCI Protocol IDs: NCI-98-C-0023, NCI-T97-0089, T97-0089
|
|
16.
|
Phase: Phase II Type: Treatment Status: Completed Age: Not specified Sponsor: NCI Protocol IDs: NCI-98-C-0040, NCI-T97-0092, T97-0092, NCT00019396
|
|
17.
|
Phase: Phase II Type: Treatment Status: Closed Age: 18-79 Sponsor: NCI Protocol IDs: UVACC-HIC-7621, UVA-HIC-7621, NCI-G98-1389, NCT00003222
|
|
18.
|
Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: LAC-USC-10M971, LAC-USC-FDR001101, NCI-T97-0100, NCT00003274, T97-0100
|
|
19.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-98-C-0095, NCI-T98-0012, T98-0012, NCT00019487
|
|
20.
|
Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: LAC-USC-10M973, NCI-G98-1432, NCI-T97-0099, NCT00003339, T97-0099
|
|
21.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: MSKCC-98012, NCI-T97-0110, NCT00003362, T97-0110
|
|
22.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-98-C-0142, NCI-T98-0036, T98-0036
|
|
23.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: 980139, 98-C-0139, NCI-98-C-0139, NCI-T97-0081, T97-0081, NCT00019526, NCT00001703
|
|
24.
|
Phase: Phase II Type: Treatment Status: Completed Age: 16 and over Sponsor: NCI Protocol IDs: CWG-UIC-T98-0027, NCI-T98-0027, NCT00003568, T98-0027
|
|
25.
|
Phase: Phase II Type: Treatment Status: Completed Age: 16 and over Sponsor: NCI Protocol IDs: NCI-99-C-0092, NCI-T99-0033, T99-0033, NCT00019721
|